These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23972990)

  • 1. Opposing effect of EGFRWT on EGFRvIII-mediated NF-κB activation with RIP1 as a cell death switch.
    Puliyappadamba VT; Chakraborty S; Chauncey SS; Li L; Hatanpaa KJ; Mickey B; Noorani S; Shu HK; Burma S; Boothman DA; Habib AA
    Cell Rep; 2013 Aug; 4(4):764-75. PubMed ID: 23972990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII.
    Li L; Chakraborty S; Yang CR; Hatanpaa KJ; Cipher DJ; Puliyappadamba VT; Rehman A; Jiwani AJ; Mickey B; Madden C; Raisanen J; Burma S; Saha D; Wang Z; Pingle SC; Kesari S; Boothman DA; Habib AA
    Oncogene; 2014 Aug; 33(33):4253-64. PubMed ID: 24077285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cytosolic ATM/NEMO/RIP1 complex recruits TAK1 to mediate the NF-kappaB and p38 mitogen-activated protein kinase (MAPK)/MAPK-activated protein 2 responses to DNA damage.
    Yang Y; Xia F; Hermance N; Mabb A; Simonson S; Morrissey S; Gandhi P; Munson M; Miyamoto S; Kelliher MA
    Mol Cell Biol; 2011 Jul; 31(14):2774-86. PubMed ID: 21606198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.
    Li L; Puliyappadamba VT; Chakraborty S; Rehman A; Vemireddy V; Saha D; Souza RF; Hatanpaa KJ; Koduru P; Burma S; Boothman DA; Habib AA
    Oncogene; 2015 Jan; 34(1):129-134. PubMed ID: 24362532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenopus death-domain-containing proteins FADD and RIP1 synergistically activate JNK and NF-kappaB.
    Ishizawa YH; Tamura K; Yamaguchi T; Matsumoto K; Komiyama M; Takamatsu N; Shiba T; Ito M
    Biol Cell; 2006 Aug; 98(8):465-78. PubMed ID: 16597320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
    Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
    Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
    Tanaka K; Babic I; Nathanson D; Akhavan D; Guo D; Gini B; Dang J; Zhu S; Yang H; De Jesus J; Amzajerdi AN; Zhang Y; Dibble CC; Dan H; Rinkenbaugh A; Yong WH; Vinters HV; Gera JF; Cavenee WK; Cloughesy TF; Manning BD; Baldwin AS; Mischel PS
    Cancer Discov; 2011 Nov; 1(6):524-38. PubMed ID: 22145100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination.
    de Almagro MC; Goncharov T; Newton K; Vucic D
    Cell Death Dis; 2015 Jun; 6(6):e1800. PubMed ID: 26111062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired RIPK1 ubiquitination sensitizes mice to TNF toxicity and inflammatory cell death.
    Kist M; Kőműves LG; Goncharov T; Dugger DL; Yu C; Roose-Girma M; Newton K; Webster JD; Vucic D
    Cell Death Differ; 2021 Mar; 28(3):985-1000. PubMed ID: 32999468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling.
    Biton S; Ashkenazi A
    Cell; 2011 Apr; 145(1):92-103. PubMed ID: 21458669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma.
    Park S; Hatanpaa KJ; Xie Y; Mickey BE; Madden CJ; Raisanen JM; Ramnarain DB; Xiao G; Saha D; Boothman DA; Zhao D; Bachoo RM; Pieper RO; Habib AA
    Cancer Res; 2009 Apr; 69(7):2809-16. PubMed ID: 19339267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8.
    Ikner A; Ashkenazi A
    J Biol Chem; 2011 Jun; 286(24):21546-54. PubMed ID: 21525013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Kinase-Mediated Decision Between the Life and Death.
    Engin A
    Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
    Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
    J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIP1 links inflammatory and growth factor signaling pathways by regulating expression of the EGFR.
    Ramnarain DB; Paulmurugan R; Park S; Mickey BE; Asaithamby A; Saha D; Kelliher MA; Mukhopadhyay P; Banani F; Madden CJ; Wright PS; Chakravarty S; Habib AA
    Cell Death Differ; 2008 Feb; 15(2):344-53. PubMed ID: 18007664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL.
    Grunert M; Gottschalk K; Kapahnke J; Gündisch S; Kieser A; Jeremias I
    Cell Death Dis; 2012 Oct; 3(10):e414. PubMed ID: 23096115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling.
    O'Donnell MA; Legarda-Addison D; Skountzos P; Yeh WC; Ting AT
    Curr Biol; 2007 Mar; 17(5):418-24. PubMed ID: 17306544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.
    Alvarez SE; Harikumar KB; Hait NC; Allegood J; Strub GM; Kim EY; Maceyka M; Jiang H; Luo C; Kordula T; Milstien S; Spiegel S
    Nature; 2010 Jun; 465(7301):1084-8. PubMed ID: 20577214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
    Yang W; Xia Y; Cao Y; Zheng Y; Bu W; Zhang L; You MJ; Koh MY; Cote G; Aldape K; Li Y; Verma IM; Chiao PJ; Lu Z
    Mol Cell; 2012 Dec; 48(5):771-84. PubMed ID: 23123196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1.
    Xu G; Tan X; Wang H; Sun W; Shi Y; Burlingame S; Gu X; Cao G; Zhang T; Qin J; Yang J
    J Biol Chem; 2010 Jan; 285(2):969-78. PubMed ID: 19910467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.